Access the full text.
Sign up today, get DeepDyve free for 14 days.
COVID-19 ACIP vaccine recommendations
(1985)
Opinion EditorialASA News
Laura Zambrano, S. Ellington, P. Strid, R. Galang, T. Oduyebo, Van Tong, K. Woodworth, John Nahabedian, E. Azziz‐Baumgartner, S. Gilboa, D. Meaney-Delman, A. Akosa, Carolyne Bennett, V. Burkel, Daniel Chang, Augustina Delaney, C. Fox, I. Griffin, J. Hsia, K. Krause, Elizabeth Lewis, Susan Manning, Yousra Mohamoud, S. Newton, V. Neelam, E. Olsen, Mirna Perez, Megan Reynolds, Aspen Riser, Maria Rivera, Nicole Roth, Christina Sancken, Neha Shinde, A. Smoots, M. Snead, Bailey Wallace, Florence Whitehill, E. Whitehouse, L. Zapata (2020)
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020Morbidity and Mortality Weekly Report, 69
J. Allotey, E. Stallings, M. Bonet, M. Yap, S. Chatterjee, T. Kew, L. Debenham, A. Llavall, A. Dixit, Dengyi Zhou, R. Balaji, S. Lee, X. Qiu, Mingyang Yuan, Dyuti Coomar, M. Wely, E. Leeuwen, E. Kostova, H. Kunst, A. Khalil, Simon Tiberi, V. Brizuela, N. Broutet, E. Kara, Caron Kim, A. Thorson, O. Oladapo, L. Mofenson, J. Zamora, S. Thangaratinam (2020)
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysisThe BMJ, 370
Samuel Cohen, Caitlyn Kellogg, O. Equils (2020)
Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine developmentHuman Vaccines & Immunotherapeutics, 17
Pfizer-BioNTech COVID-19 vaccine
A. Cavaliere, L. Marchi, D. Aquilini, T. Brunelli, P. Vasarri (2020)
Passive immunity in newborn from SARS‐CoV‐2‐infected motherJournal of Medical Virology, 93
S. Madhi, F. Polack, P. Piedra, F. Muñoz, A. Trenholme, E. Simões, G. Swamy, Sapeckshita Agrawal, K. Ahmed, A. August, A. Baqui, A. Calvert, Janice Chen, I. Cho, M. Cotton, C. Cutland, J. Englund, Amy Fix, B. Gonik, L. Hammitt, P. Heath, Joanne Jesus, C. Jones, A. Khalil, D. Kimberlin, R. Libster, C. Llapur, M. Lucero, Gonzalo Marc, H. Marshall, Masebole Masenya, F. Martinón-Torres, J. Meece, T. Nolan, Ayman Osman, K. Perrett, J. Plested, P. Richmond, M. Snape, J. Shakib, V. Shinde, Tanya Stoney, D. Thomas, A. Tita, M. Varner, M. Vatish, K. Vrbicky, J. Wen, K. Zaman, H. Zar, G. Glenn, L. Fries (2020)
Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infantsThe New England Journal of Medicine, 383
L. Toner, S. Gelber, J. Peña, N. Fox, A. Rebarber (2020)
A Case Report to Assess Passive Immunity in a COVID Positive Pregnant PatientAmerican Journal of Perinatology, 37
K. Woodworth, E. Olsen, V. Neelam, Elizabeth Lewis, R. Galang, T. Oduyebo, Kathryn Aveni, M. Yazdy, Elizabeth Harvey, Nicole Longcore, Jerusha Barton, C. Fussman, Samantha Siebman, Mamie Lush, Paul Patrick, Umme-Aiman Halai, Miguel Valencia-Prado, L. Orkis, Similoluwa Sowunmi, Levi Schlosser, Salma Khuwaja, J. Read, A. Hall, D. Meaney-Delman, S. Ellington, S. Gilboa, Van Tong, Augustina Delaney, J. Hsia, Kellianne King, Mirna Perez, Megan Reynolds, Aspen Riser, Maria Rivera, Christina Sancken, John Sims, A. Smoots, M. Snead, P. Strid, Tineka Yowe-Conley, Laura Zambrano, L. Zapata, Susan Manning, V. Burkel, A. Akosa, Carolyne Bennett, I. Griffin, John Nahabedian, S. Newton, Nicole Roth, Neha Shinde, E. Whitehouse, Daniel Chang, C. Fox, Yousra Mohamoud, Florence Whitehill (2020)
Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020Morbidity and Mortality Weekly Report, 69
(2020)
CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy
K. Dooling, M. Marin, Megan Wallace, Nancy McClung, M. Chamberland, Grace Lee, H. Talbot, J. Romero, B. Bell, Sara Oliver (2021)
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020Morbidity and Mortality Weekly Report, 69
A. Edlow, Jonathan Li, Ai-ris Collier, C. Atyeo, K. James, A. Boatin, K. Gray, E. Bordt, L. Shook, L. Yonker, A. Fasano, K. Diouf, Natalie Croul, Samantha Devane, L. Yockey, Rosiane Lima, J. Shui, Juan Matute, P. Lerou, B. Akinwunmi, A. Schmidt, J. Feldman, B. Hauser, T. Caradonna, Denis Flor, P. D’Avino, J. Regan, H. Corry, Kendyll Coxen, Jesse Fajnzylber, D. Pépin, M. Seaman, D. Barouch, B. Walker, Xu Yu, A. Kaimal, D. Roberts, G. Alter (2020)
Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 PandemicJAMA Network Open, 3
(2021)
and Drug Administration
G. Bwire, B. Njiro, D. Mwakawanga, Deodatus Sabas, B. Sunguya (2020)
Possible vertical transmission and antibodies against SARS‐CoV‐2 among infants born to mothers with COVID‐19: A living systematic reviewJournal of Medical Virology, 93
Bwire (2020)
1J Med Virol
CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team; COVID-19 Pregnancy and Infant Linked Outcomes Team (PILOT)
D. Flannery, S. Gouma, Miren Dhudasia, S. Mukhopadhyay, M. Pfeifer, E. Woodford, Jourdan Triebwasser, J. Gerber, Jeffrey Morris, M. Weirick, C. McAllister, M. Bolton, C. Arevalo, E. Anderson, E. Goodwin, S. Hensley, K. Puopolo (2021)
Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios.JAMA pediatrics
Milena Dutra, Atividade Física, Adaptada Gestação (1979)
American College of Obstetricians and GynecologistsJournal of the American Dietetic Association
Opinion EDITORIAL Can We Protect Pregnant Women and Young Infants From COVID-19 Through Maternal Immunization? Flor M. Munoz, MD Infection with severe acute respiratory syndrome coronavi- The time available for antibody transfer is another impor- rus 2 (SARS-CoV-2) during pregnancy and early infancy can re- tant factor. Flannery et al were able to ascertain that placen- 1-3 sult in severe disease. Less is known about the immune re- tal transfer ratios increased when the time between maternal sponses of pregnant women with coronavirus disease 2019 infection and delivery was longer. This finding is consistent (COVID-19) and the possibil- with similar observations on the transfer of antibodies in re- ity for infant protection. Vac- cent studies of a respiratory syncytial virus vaccine given dur- Related article page 594 cination of pregnant women ing pregnancy, where an interval of 30 days or more from vac- with SARS-CoV-2 vaccines in development has begun in the cination to delivery was significantly associated with higher United States in the context of emergency use authorized vac- antibody transfer. Interestingly, the transfer ratio of SARS- cine deployment for high-risk priority groups and guidance CoV-2 antibodies was not affected by premature delivery (ges- from the US Centers
JAMA Pediatrics – American Medical Association
Published: Jun 29, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.